Researchers continue to excited about the medication , a groundbreaking dual compound showing significant data in clinical trials for size loss . It functions by modulating both systems: GLP-1 and GIP, which , when activated , help influence appetite and improve energy expenditure . Preliminary observations suggest substantial weight loss and likel